| GPR171 |
GPR171, H963: Probable G-protein coupled receptor 171 |
OR2C3 |
Olfactory receptor OR1-30 |
0.745 |
Evidence |
|
| GPR171 |
GPR171, H963: Probable G-protein coupled receptor 171 |
GPR55 |
GPR55: Probable G-protein coupled receptor 55 |
0.745 |
Evidence |
|
| GPR171 |
GPR171, H963: Probable G-protein coupled receptor 171 |
OR1A1 |
OR1A1: Olfactory receptor 1A1 |
0.745 |
Evidence |
|
| GPR171 |
GPR171, H963: Probable G-protein coupled receptor 171 |
GHSR |
GHSR: Growth hormone secretagogue receptor type 1 |
0.745 |
Evidence |
|
| CCBP2 |
CCBP2, CCR10, CMKBR9: Chemokine-binding protein 2 |
OR2C3 |
Olfactory receptor OR1-30 |
0.745 |
Evidence |
|
| CCBP2 |
CCBP2, CCR10, CMKBR9: Chemokine-binding protein 2 |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
GPR63 |
GPR63, PSP24B: Probable G-protein coupled receptor 63 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
GPR174 |
GPR174, FKSG79: Probable G-protein coupled receptor 174 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
OR5P2 |
OR5P2: Olfactory receptor 5P2 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
DRD3 |
DRD3: D(3) dopamine receptor |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
FFAR1 |
FFAR1, GPR40: Free fatty acid receptor 1 |
0.745 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ASB17 |
ASB17: Ankyrin repeat and SOCS box protein 17 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
FAM62A |
FAM62A, KIAA0747, MBC2: Protein FAM62A |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
RXFP1 |
IPI00719123 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
DRD3 |
DRD3: D(3) dopamine receptor |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
FFAR1 |
FFAR1, GPR40: Free fatty acid receptor 1 |
0.745 |
Evidence |
|
| HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
RPL18A |
RPL18A: 60S ribosomal protein L18a |
0.745 |
Evidence |
|
| RPL10 |
RPL10, DXS648E, QM: 60S ribosomal protein L10 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
0.745 |
Evidence |
|